PetMed Express Inc.
PETS | NASDAQ
$1.58
-$0.02 (-1.25%)
Sep 22, 2026, 1:10 PM ET · Market open
Company Profile
PetMed Express, Inc., through its various subsidiaries, operates as a prominent pet pharmacy across the United States. The company provides a comprehensive range of both prescribed and over-the-counter animal medications, health-related items, and other essential supplies for canines, felines, and equines. Their non-prescription offerings include products for flea and tick prevention, joint and bone care, vitamins, treats, nutritional supplements, hygiene essentials, and general pet supplies. For prescription needs, they supply heartworm and flea/tick preventatives, alongside medications for conditions such as arthritis, dermatitis, thyroid imbalances, diabetes, pain relief, and cardiovascular issues, often providing generic alternatives. Beyond pharmaceuticals, the company also retails pet food, bedding, crates, stairs, and various other accessories. PetMed Express engages with its clientele through multiple distribution channels: its official website, a dedicated mobile application, a telephone contact center, direct mail campaigns (like brochures and postcards), and television advertisements, frequently promoting its 1-800-PetMeds and PetMeds brands. The company was established in 1996 and is headquartered in Delray Beach, Florida.
Key Executives
| Name | Position |
|---|---|
| Leslie C. G. Campbell | Executive Chairman of the Board, Interim CEO & President |
| Caroline Conegliano | Chief Growth Officer |
| Doug Krulik | Chief Accounting Officer, Principal Acc. Off., Interim Principal Financial Officer & Treasurer |
| Jacqueline Smith | Vice President of People |
| Robert Lawsky | Corporate Secretary & General Counsel |
| Wendy Zalai | Corporate Controller & Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 13, 2026 | 4 | Filing |
| Aug 13, 2026 | 10-Q | Quarterly Report |
| Aug 13, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Aug 13, 2026 | 8-K | Current Report |
| Aug 12, 2026 | 8-K | Current Report |
| Aug 12, 2026 | 4 | Filing |
| Aug 12, 2026 | 4 | Filing |
| Aug 12, 2026 | 4 | Filing |
| Jul 24, 2026 | 4/A | [Amend] Filing |
| Jul 23, 2026 | 8-K | Current Report |
PetMed Express Inc.
| Country | United States |
| IPO Date | Apr 25, 1999 |
| Industry | Specialty Retail |
| Sector | Consumer Cyclical |
| Employees | 189 |
| CEO | Leslie C. G. Campbell |
Contact Details
420 South Congress Avenue Delray Beach,
Florida 33445 United States
Stock Details
| Ticker Symbol | PETS |
| Exchange | NASDAQ |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| CIK Code | 0001040130 |
| CUSIP Number | 716382106 |
| ISIN Number | US7163821066 |
| SIC Code | 5912 |
Add to Watchlist
Select watchlists to add or remove PETS